Balanced news tone
News Sentiment
128940 sentiment intelligence
Hanmi Pharm. Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-15.7% over one week, -5.4% over four weeks, trend inactive, and near fair-value range.
Enterprise value to EBIT forward of Hanmi Pharmaceutical Co., Ltd. – KRX:128940
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to EBIT forward of Hanmi Pharmaceutical Co., Ltd. – KRX:128940
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 23:55
- Source
- TradingView
Hanmi Pharm holds focus on its business model.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 15:27
- Source
- ad-hoc-news.de
Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 31 May 2026 07:00
- Source
- PR Newswire
Hanmi’s efpeglenatide hits phase III endpoints in obesity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Oct 2025 07:00
- Source
- BioWorld News
Hanmi Pharm invests ₩140B to grow China production, R&D base
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Dec 2024 08:00
- Source
- BioWorld News
Korea Hanmi to launch blockbuster hypertension drug in China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2022 08:00
- Source
- KED Global